Garat, Chrystelle, Ethan P. Carter, and Michael A. Matthay. New in situ mouse model to quantify alveolar epithelial fluid clearance. J. Appl. Physiol. 84(5): 1763-1767 , 1998 .-Because the availability of transgenic mice makes it possible to examine the contribution of single genes to in vivo function, we developed a simple in situ mouse model that can be used to quantify isosmolar alveolar epithelial fluid clearance (AFC). Mice were killed, a tracheostomy was done, and then a test solution of a 5% isosmolar albumin solution with 0.1 µCi of 125 I-labeled albumin was instilled via the trachea into the distal air spaces of both lungs. After instillation, the lungs were inflated to 7 cmH 2 O with 100% O 2 and maintained at 37°C by placing the animals under an infrared lamp. AFC was measured by the progressive increase in concentration of labeled and unlabeled protein over 1 h. The results indicated the following. 1) Basal, unstimulated AFC in mouse lungs was significantly faster than in ex vivo rat lungs (27 Ϯ 5% in in situ mice vs. 11 Ϯ 3% in ex vivo rat lungs; P Ͻ 0.05).
alveolar epithelium; ␤-adrenergic agonists; pulmonary edema; sodium transport BECAUSE ADVANCES in molecular genetics have facilitated the isolation of cDNA and genes, the ability to assess the role of normal and mutated genes in transgenic mice has become an important approach for the analysis of gene function in vivo. However, specific animal models are needed to test the potential function of specific gene products. Our laboratory is particularly focused on developing methods to quantify alveolar epithelial fluid transport in the intact lung. Recently, for example, we developed a fluorescence model in isolated, perfused mouse lungs to measure osmotic water permeability (5) . The overall goal of the present study was to develop an in situ mouse model to study isosmolar alveolar epithelial fluid clearance (AFC). Because prior studies from our laboratory (25, 26) and others (9) demonstrated that the rate of short-term AFC was not adversely affected by the absence of perfusion or ventilation to the lung, our first objective was to develop an in situ mouse model that would be useful for quantifying isosmolar AFC over a 1-h period.
Once the model was successfully established, the second objective was to determine the rate of basal AFC in the mouse. The third objective was to determine the effect of ␤-adrenergic stimulation on AFC in mice. The fourth objective was to compare the basal and stimulated AFC data in the nonperfused mouse lungs with our previously published data in clearance rates in nonperfused lungs of sheep and rats as well as with our recent data on clearance rates from patients during the resolution of hydrostatic pulmonary edema.
METHODS
For all experiments, male c57 mice (Benton-Kingman, Fremont, CA) weighing 20-25 g were used. The mice were housed in air-filtered, temperature-controlled units with food and water. All of the procedures conformed to the guidelines of the University of California-San Francisco Committee on Animal Research.
Experimental Preparation
Mice were killed with an overdose of pentobarbital sodium (150 mg/kg ip). Within 2 min of death, the trachea was transected and cannulated with a 20-gauge trimmed Angiocath plastic needle (Becton Dickinson, Sandy, UT). The mice were maintained in a decubitus position throughout the experiment. Continuous positive airway pressure (CPAP) with 7 cmH 2 O with 100% O 2 was delivered for the duration of the 1-h experiment, as has been done previously (25) . This was done to avoid airway and alveolar collapse, to maintain a homogeneous instillate distribution, and to ensure adequate tissue oxygenation. Body temperature was maintained at 37-38°C with a thermostatically controlled pad. A temperature probe (Yellow Springs Instrument, Yellow Springs, OH) that was used to monitor core temperature throughout the experiment was inserted via a 0.5-cm incision into the abdominal cavity. In preliminary experiments, we found that additional thermal regulation could be achieved with an infrared lamp (Fisher, Santa Clara, CA) placed ϳ30 cm above the body. The lamp was cycled on and off to maintain the core temperature at 37-38°C.
Preparation of Instillate
The instillate consisted of 5% BSA (Sigma Chemical, St. Louis, MO) with Ringer lactate, as previously published (10, 14, 23) . We added 0.1 µCi of 125 I-labeled albumin (MerckFrosst, Montreal, PQ, Canada) to the instillate as an alveolar protein tracer. Amiloride, terbutaline, atenolol (Sigma Chemical), benzamil (Research Biochemicals International, Natick, MA), propranolol (SoloPak; SoloPak Laboratories, Elk Grove Village, IL), salmeterol (gift from Glaxo, Hertfordshire, UK), and isoproterenol (Sanofi Winthrop Pharmaceuticals, New York, NY) were added to the instillate in selected studies, as described in the specific protocol.
General Protocol
For all studies, the following protocol was used. After we established the tracheostomy and inserted the temperature 8750-7587/98 $5.00 Copyright 1998 the American Physiological Society probe, the instillate (20 ml/kg; 0.51 Ϯ 0.02 ml of an isosmolar 5% albumin Ringer lactate solution with 125 I-labeled albumin) was delivered over 30 s into both lungs through the tracheal cannula. At the end of the experiment, 1 h after beginning the instillation, the lungs were removed through a median sternotomy. An alveolar fluid sample (0.1-0.2 ml) was aspirated with a small catheter (PE-10) and was centrifuged at 3,000 g for 10 min. The supernatant of the fluid was obtained for measurement of the total protein concentration and radioactivity. We reported in a prior study (3) that the concentration of the protein tracers in the liquid sampled by a small catheter wedged into the distal airways was the same as the concentration in an alveolar micropuncture sample.
In preliminary studies, we determined that 0.5 ml was the optimal volume for the instillate, on the basis of the feasibility of recovering an adequate fluid volume for protein and radioactivity measurements after 1 h. Additional studies, using 0.3 or 0.4 ml as the instillate, were included for comparison with the 0.5-ml instillate group for basal clearance to determine whether the larger volume of instillate affected the rate of clearance.
Specific Protocol
Group 1: control studies (n ϭ 6). We instilled 0.51 Ϯ 0.02 ml of 5% albumin solution in Ringer lactate, with the protein tracer 125 I-labeled albumin, into both lungs. Also, to be certain that the high rate of basal clearance was not simply a function of the 0.5 ml instilled volume, five additional mice were studied with lower instilled volumes (0.3 and 0.4 ml).
Group 2: effect of amiloride (10 Ϫ3 M, n ϭ 6) and benzamil (10 Ϫ3 M, n ϭ 5) on AFC. The effect of amiloride on alveolar fluid transport has been studied by our laboratory (10, 14, 23) and by other investigators (1, 2, 6-8). The dose of 10 Ϫ3 M amiloride was used in this study, because our objective was to have an effective amiloride concentration of 10 Ϫ4 M in the air spaces. According to prior studies of amiloride-concentration measurements in the air spaces of rabbit lung, amiloride declines by ϳ10-fold over 2 h (21) . Therefore, the effective concentration over 1 h would be 2 ϫ 10 Ϫ4 M. Also, because our instilled alveolar solution contained 5% albumin, we empirically determined that another 50% reduction in functional amiloride concentration (to 10 Ϫ4 M) is caused by nonspecific binding to albumin (11) . Approximately 40-50% of basal AFC in rats is inhibited by 10 Ϫ3 M amiloride (10, 14) . Because amiloride at 10 Ϫ4 M may inhibit the Na ϩ -H ϩ -antiporter and the Na ϩ -K ϩ -ATPase, an additional set of experiments was carried out by using 10 Ϫ3 M benzamil, a Na ϩ channel blocker. These experiments were performed only to eliminate the confounding effects of nonspecific binding to albumin in Ringer's lactate solution.
Group 3: effect of propranolol on AFC (n ϭ 5). Propranolol (10 Ϫ4 M) was added to the instillate to determine whether the high rate of basal AFC in mice was mediated by stimulation of ␤-Adrenergic receptors by endogenous catecholamine release.
Group 4: terbutaline (n ϭ 4) and salmeterol studies (n ϭ 5). ␤-adrenergic agonist therapy stimulates AFC in several species. We used two ␤ 2 -adrenergic receptor agonists with markedly different potencies [apparent dissociation constant ϭ 50 nM for salmeterol and 5,500 nM for terbutaline (16) ] to determine whether ␤ 2 -receptor stimulation increases the rate of AFC. Terbutaline (10 Ϫ4 M) or salmeterol (10 Ϫ4 M) was added to the 5% albumin instillate solution.
Group 5: isoproterenol studies (n ϭ 4). To determine the effect of isoproterenol (␤ 1 -and ␤ 2 -adrenergic agonist) on AFC, 10 Ϫ4 M isoproterenol was added to the instillate.
Group 6: isoproterenol plus atenolol studies (n ϭ 4). To determine whether the effect of isoproterenol was mediated by a ␤ 1 -adrenergic receptor, we added 10 Ϫ4 M of atenolol, a ␤ 1 -adrenergic antagonist, to the albumin solution with 10 Ϫ4 M isoproterenol.
Measurement of AFC
As in our previous studies (10, 14, 23) , AFC was calculated by measuring the increase in albumin (either labeled or nonlabeled) concentration of the instilled albumin solution. AFC was calculated as AFC ϭ
Fw is the water fraction of the initial (i) and the final (f ) alveolar fluid. The Fw is the volume of water per volume of solution measured by the gravimetric method. V i is the volume of the initial alveolar fluid, and V f , of the final. V f (in ml) was estimated as V f ϭ (V i ϫ TP i ϫ Fr)/TP f , where TP is the total protein concentration of the initial and final alveolar fluid. Fr is the fraction of alveolar tracer ( 125 I-albumin) protein that remains in the lung at the end of the experiment.
Protein concentration was determined by the Biuret method with the use of spectrophotometry. The concentration of 125 I-albumin was measured by gamma counting.
Measurement of Alveolar Barrier Integrity
As an index of alveolar barrier integrity, we used the residual 125 I-albumin in the lung at the end of the experiment (10, 14, 22) . In each experiment, Ͼ97% of the total radioactivity that was instilled at the beginning of the experiment was recovered from the final aspirate, lungs, and tracheal cannula. This indicates that the alveolar epithelial barrier remained largely intact even in the presence of 7 cmH 2 O CPAP.
Statistical Analysis
The data are summarized as means Ϯ SD. The one-way analysis of variance and Fisher's exact test were used to compare the different animal groups. We regarded a P value of Ͻ0.05 as statistically significant.
RESULTS
Basal AFC: Effect of Amiloride (10 Ϫ3 M), Benzamil (10 Ϫ3 M), and Propranolol (10 Ϫ4 M) on Basal Clearance AFC was similar, whether it was calculated from the concentration of unlabeled or labeled albumin in the final alveolar fluid samples (Fig. 1) . In the presence of amiloride, AFC was reduced significantly by ϳ35% at 1 h (final-to-instilled protein concentration ratio, 1.27 Ϯ 0.05 in controls vs. 1.18 Ϯ 0.07 with amiloride; P Ͻ 0.05) (Fig. 1) . Because relatively high concentrations of amiloride may have some inhibitory effects not related to amiloride-sensitive Na ϩ channels, an additional set of experiments was carried out using benzamil, a Na ϩ channel blocker. In the presence of 10 Ϫ3 M benzamil, AFC was significantly reduced by 30% over 1 h (final-toinstilled alveolar protein-tracer concentration ratio of 1.23 Ϯ 0.03 in controls vs. 1.16 Ϯ 0.03 with benzamil; P Ͻ 0.05). In contrast, propranolol had no effect on basal AFC (final-to-instilled protein concentration ratio of 1.29 Ϯ 0.03 with propranolol compared with 1.27 Ϯ 0.05 in controls), indicating that there was no adrenergic stimulation in the basal condition.
Basal unstimulated AFC in mice was 145% higher than the basal rate reported in ex vivo rat lungs over 1 h (25) and was much higher than the basal rate reported in nonperfused sheep lungs over 1 h (26) ( Table 1 ). To be certain that the fast rate of clearance in mice was not a function of the larger instilled volume, additional studies were done in five mice with instillate volumes that were 20 or 40% smaller (0.4 or 0.3 ml, respectively). The final-to-instilled concentration ratios of alveolar protein tracer ( 125 I-albumin) were similar with either 0.4 or 0.3 ml as the instillate volume. The combined data from these studies showed a final-toinstilled alveolar protein tracer-concentration ratio of 1.32 Ϯ 0.05 compared with 1.23 Ϯ 0.03 for the main experiments with the use of 0.5 ml as the instillate. Thus, AFC had a tendency to be slightly faster in the lower instillate volumes (34 Ϯ 4%, as reflected by the rise in the alveolar protein tracer concentration), but the difference did not reach statistical significance.
Stimulated AFC: Effect of Terbutaline (10 Ϫ4 M), Salmeterol (10 Ϫ4 M), and Isoproterenol (10 Ϫ4 M)
Addition of either terbutaline or salmeterol, a new lipid-soluble ␤ 2 -adrenergic agonist which has 100 times the receptor affinity of terbutaline (16) , to the instilled albumin solution did not increase AFC (final-toinstilled protein concentration ratio of 1.22 Ϯ 0.02 in the presence of terbutaline and 1.21 Ϯ 0.06 in the presence of salmeterol, compared with 1.23 Ϯ 0.03 in the control studies). Thus, two independent ␤ 2 -adrenergic agonists with markedly different potencies did not stimulate AFC above the basal rate. In contrast, isoproterenol markedly increased AFC (Figs. 1 and 2 ). This finding stimulated subsequent studies to determine whether the effect of isoproterenol was mediated by the ␤ 1 -adrenergic receptor. Atenolol (10 Ϫ4 M) inhibited the isoproterenol-induced increase in AFC (Fig. 2) .
DISCUSSION
The continued development of transgenic mouse models requires new methods to evaluate lung function in newly expressed phenotypes. In particular, the ability of the air spaces to remain dry is necessary for effective gas exchange, a critical function that could be altered in transgenic mice (12) .
The first objective was to develop a practical in situ mouse model that could be used by other investigators to study isosmolar AFC in the mouse lungs. It was possible to achieve this objective by adapting methods for the in situ mouse lung based on our prior experiments in other species (15, 26, 29) , including human lungs (25) .
The second objective of these experiments in this new model was to characterize the isosmolar fluid transport properties of the alveolar epithelium in mice. The ability to transport fluid out of the air spaces was studied under basal conditions in the presence of amiloride or propranolol, as well as with ␤-adrenergic stimulation. AFC was measured by the progressive increase in the protein concentration of a 5% albumin solution instilled into the distal air spaces of the lungs. This method has proven to be reliable under normal (14) and even under pathological conditions (10, 22, 23) . Interestingly, basal AFC was faster in the in situ mouse lungs than the basal rates reported in several other species. In the in situ mouse lungs, basal AFC was 27 Ϯ 5% of instilled fluid for 1 h. Protein concentration increased from 5.1 Ϯ 0.5 g/dl in the initial alveolar fluid to 6.4 Ϯ 0.5 g/dl in final alveolar fluid (P Ͻ 0.05). In similar nonperfused preparations, the rate of clearance was 11 Ϯ 3% of instilled fluid over 1 h in rats (25) and 24 Ϯ 8% over 4 h in sheep (26) .
Several potential mechanisms could explain the high basal clearance rate in mice. First, an endogenous release of catecholamines accompanying the systemic hypotension from the barbituate overdose at the time of death might increase AFC. Catecholamines are known to stimulate AFC through the activation of both amiloride-sensitive Na ϩ channels (17, 18, 22) and the Na ϩ -K ϩ -ATPase in alveolar type II cells (30) . Catecholamine stimulation operates via ␤-adrenergic stimulation, resulting in increased intracellular cAMP levels leading to phosphorylation and activation of vectorial Na ϩ transport (27) . To test this possibility, propranolol was administered with the 5% albumin solution into the air spaces of the lungs. As we reported in other species (4, 14) , propranolol had no effect on basal AFC.
A second explanation for the high basal clearance rate observed in mice could be the large volume of alveolar instillate relative to the body weight. Previous investigators have used different relative instillate volumes ranging from 1.5 to 17.0 ml/kg body weight (1, 19) . In the present study, we used an instilled volume of 20 ml/kg body weight, because the larger instilled volume facilitated sampling of alveolar fluid at the end of the 1-h experiment. It seemed possible that the high basal rate of clearance we observed in mice compared with other species could be caused by the larger relative instillate volume that we used. To test this possibility, we carried out additional experiments, using different degrees of fluid filling of the lung (12 and 16 ml/kg body weight). Interestingly, not only was the larger relative instillate volume not responsible for the high basal rate observed in mice, it actually may have decreased the basal rate of clearance, because the rate was slightly faster with the lower instillate volumes. However, from a practical perspective, the 0.5-ml volume may be best for carrying out 1-h AFC experiments, because this volume allows for retrieval of a large enough air space sample to measure two independent markers of clearance ( 125 I-albumin and total protein).
Finally, the nature of the nonperfused model itself could influence the basal rate of clearance. This was not the case in other larger animal models in which both perfused and nonperfused experiments have been carried out (15, 26) . However, it cannot be ruled out in mice until a suitable in vivo model is developed that allows for adequate sampling of air space solutions at the end of 60-min experiments. Recent preliminary evidence from Icard et al. (13) indicates similar rates of clearance between the nonperfused mouse model in this study and their experiments with isolated, perfused mice lungs. Also, they reported that mice remove alveolar fluid twice as rapidly as rats normalized for the same quantity of lung tissue.
A novel observation in the present study is the finding that ␤ 1 -and not ␤ 2 -adrenergic stimulation increased AFC. This finding was elucidated pharmacologically through the use of a general ␤-adrenergic agonist (isoproterenol), specific ␤ 2 -adrenergic agonists (terbutaline and salmeterol), and a specific ␤ 1 -antagonist (atenolol). This observation is distinctly different from observations in rats (17, 31) but similar to results that have been reported recently in guinea pigs (20) . The significance of this strain and/or species specificity is not yet clear, although the data for guinea pigs indicate that cAMP signaling in some species may be greater with ␤ 1 -rather than ␤ 2 -stimulation. The magnitude of stimulation with isoproterenol was modest (40% over basal levels), perhaps partly because basal clearance is already high in mice.
To confirm that AFC is driven by active Na ϩ transport, amiloride or benzamil was used to inhibit Na ϩ uptake (and subsequent transepithelial transport) by alveolar type II cells. The inhibitory pattern observed is similar to what has been reported by others with respect to alveolar fluid and Na ϩ clearance (1, 2, 5, 7, 8, 10, 14) . However, it is possible that factors such as changes in surface area could have accounted for some of the observed differences, although this effect would most likely be minor.
Benzamil or amiloride inhibited ϳ30-35% of basal AFC, slightly less than percentages obtained in studies of rat lungs (1, 2, 5, 7, 8, 10, 14) . This means that Ͼ50% of Na ϩ reabsorption is amiloride insensitive. The pathway for the amiloride-insensitive fraction of transport has remained elusive. Recently, in situ hybridization of mRNA encoding for nucleotide-gated cation channels was reported in alveolar type I cells (28) . If type I cells also participate in transepithelial Na ϩ transport by means of nucleotide-gated cation channels, these channels may contribute to Na ϩ balance in the terminal parts of the lungs. There are also new data that the ␣ 2 -isoform of Na ϩ -K ϩ -ATPase is expressed in alveolar type I-like cells; these data raise the possibility that these cells may participate in vectorial Na ϩ transport (24) .
In summary, AFC can be quantified in an in situ mouse model over 1 h. The basal clearance rates in mice are faster than those reported in similar in situ experimental models in sheep and rats. Also, the ␤ 1 -adrenergic receptor appears to be responsible for a modest upregulation of AFC in mice. The fast basal and stimulated rates are similar to the maximal AFC rates that were recently reported in patients during the resolution of pulmonary hydrostatic edema (32) . This new murine model will be useful to investigators in the field of alveolar epithelial fluid transport.
